Predictive value of C-reactive protein for tuberculosis, bloodstream infection or death among HIV-infected individuals with chronic, non-specific symptoms and negative sputum smear microscopy.
Authors
Bedell, RAvan Lettow, M
Meaney, C
Corbett, EL
Chan, AK
Heyderman, RS
Anderson, ST
Akesson, A
Kumwenda, M
Zachariah, R
Harries, AD
Ramsay, AR
Issue Date
2018-01-01Submitted date
2019-07-11
Metadata
Show full item recordAbstract
BACKGROUND: C-reactive protein (CRP) is an inflammatory biomarker that may identify patients at risk of infections or death. Mortality among HIV-infected persons commencing antiretroviral therapy (ART) is often attributed to tuberculosis (TB) or bloodstream infections (BSI). METHODS: In two district hospitals in southern Malawi, we recruited HIV-infected adults with one or more unexplained symptoms present for at least one month (weight loss, fever or diarrhoea) and negative expectorated sputum microscopy for TB. CRP determination for 452 of 469 (96%) participants at study enrolment was analysed for associations with TB, BSI or death to 120 days post-enrolment. RESULTS: Baseline CRP was significantly elevated among patients with confirmed or probable TB (52), BSI (50) or death (60) compared to those with no identified infection who survived at least 120 days (269). A CRP value of >10 mg/L was associated with confirmed or probable TB (adjusted odds ratio 5.7; 95% CI 2.6, 14.3; 87% sensitivity) or death by 30 days (adjusted odds ratio 9.2; 95% CI 2.2, 55.1; 88% sensitivity). CRP was independently associated with TB, BSI or death, but the prediction of these endpoints was enhanced by including haemoglobin (all outcomes), CD4 count (BSI, death) and whether ART was started (death) in logistic regression models. CONCLUSION: High CRP at the time of ART initiation is associated with TB, BSI and early mortality and so has potential utility for stratifying patients for intensified clinical and laboratory investigation and follow-up. They may also be considered for empirical treatment of opportunistic infections including TB.Publisher
Wiley-BlackwellPubMed ID
29243878Language
enISSN
1365-3156ae974a485f413a2113503eed53cd6c53
10.1111/tmi.13025
Scopus Count
Collections
Related articles
- Six-month mortality among HIV-infected adults presenting for antiretroviral therapy with unexplained weight loss, chronic fever or chronic diarrhea in Malawi.
- Authors: van Lettow M, Åkesson A, Martiniuk AL, Ramsay A, Chan AK, Anderson ST, Harries AD, Corbett E, Heyderman RS, Zachariah R, Bedell RA
- Issue date: 2012
- High prevalence of tuberculosis and serious bloodstream infections in ambulatory individuals presenting for antiretroviral therapy in Malawi.
- Authors: Bedell RA, Anderson ST, van Lettow M, Akesson A, Corbett EL, Kumwenda M, Chan AK, Heyderman RS, Zachariah R, Harries AD, Ramsay AR
- Issue date: 2012
- Tuberculosis and non-tuberculous mycobacteria among HIV-infected individuals in Ghana.
- Authors: Bjerrum S, Oliver-Commey J, Kenu E, Lartey M, Newman MJ, Addo KK, Hilleman D, Andersen AB, Johansen IS
- Issue date: 2016 Sep
- Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis.
- Authors: Lawn SD, Kerkhoff AD, Vogt M, Wood R
- Issue date: 2013 May
- Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study.
- Authors: Akanbi MO, Achenbach C, Taiwo B, Idoko J, Ani A, Isa Y, Agbaji O, Ukoli C, Akande P, Maiga M, Murphy RL
- Issue date: 2017 May 30